Torrent Pharmaceuticals
- Advice
- Hold
Torrent Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Torrent Pharmaceuticals
Start SIPTorrent Pharmaceuticals Investment Rating
-
Master Rating:
-
Torrent Pharmaceuticals has an operating revenue of Rs. 9,260.00 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 14% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 36%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 1,857 | 1,928 | 1,933 | 1,662 |
| Operating Expenses Qtr Cr | 1,272 | 1,308 | 1,268 | 1,179 |
| Operating Profit Qtr Cr | 585 | 620 | 665 | 483 |
| Depreciation Qtr Cr | 156 | 156 | 149 | 147 |
| Interest Qtr Cr | 91 | 62 | 51 | 52 |
| Tax Qtr Cr | 124 | 141 | 167 | 124 |
| Net Profit Qtr Cr | 229 | 272 | 327 | 221 |
Torrent Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- 1515.25
- 50 Day
- 1528.01
- 100 Day
- 1540.94
- 200 Day
- 1529.44
- 20 Day
- 1502.58
- 50 Day
- 1529.14
- 100 Day
- 1572.75
- 200 Day
- 1539.14
Torrent Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 1535.32 |
| Second Resistance | 1548.94 |
| Third Resistance | 1565.87 |
| RSI | 49.47 |
| MFI | 60.92 |
| MACD Single Line | -3.1 |
| MACD | 1.99 |
| Support | |
|---|---|
| First Resistance | 1504.77 |
| Second Resistance | 1487.84 |
| Third Resistance | 1474.22 |
Torrent Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 223,747 | 10,504,922 | 46.95 |
| Week | 270,629 | 11,447,615 | 42.3 |
| 1 Month | 259,594 | 13,857,135 | 53.38 |
| 6 Month | 267,332 | 15,457,132 | 57.82 |
Torrent Pharmaceuticals Result Highlights
Torrent Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Torrent Pharmac is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 6742.32 Cr. and Equity Capital is Rs. 84.62 Cr. for the Year ended 31/03/2022. Torrent Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/07/1972 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1972PLC002126 and registration number is 002126.| Market Cap | 51,274 |
| Sales | 7,380 |
| Shares in Float | 9.81 |
| No of funds | 587 |
| Yield | 1.45 |
| Book Value | 8.08 |
| U/D Vol ratio | 0.8 |
| LTDebt / Equity | 31 |
| Alpha | 0.05 |
| Beta | 0.56 |
Torrent Pharmaceuticals
| Owner Name | Dec-22 | Sep-22 | Jul-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 71.25% | 71.25% | 71.25% | |
| Mutual Funds | 6.23% | 6.72% | 7.72% | |
| Insurance Companies | 1.99% | 2.16% | 0.04% | |
| Foreign Portfolio Investors | 12.09% | 11.37% | 10.79% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 4.72% | 4.59% | 7.13% | |
| Others | 3.72% | 3.91% | 3.07% |
Torrent Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Sudhir Mehta | Chairman Emeritus |
| Mr. Samir Mehta | Executive Chairman |
| Mr. Shailesh Haribhakti | Independent Director |
| Mr. Haigreve Khaitan | Independent Director |
| Ms. Ameera Shah | Independent Director |
| Ms. Nayantara Bali | Independent Director |
| Dr. Maurice Chagnaud | Independent Director |
| Mr. Jinesh Shah | Director - Operations |
| Mr. Manish Mahendra Choksi | Independent Director |
| Mr. Aman Samir Mehta | Whole Time Director |
Torrent Pharmaceuticals Forecast
Price Estimates
About Company
Torrent Pharmaceuticals FAQs
What is Share Price of Torrent Pharmaceuticals ?
Torrent Pharmaceuticals share price is ₹1515 As on 22 March, 2023 | 06:09
What is the Market Cap of Torrent Pharmaceuticals ?
The Market Cap of Torrent Pharmaceuticals is ₹51274.5 Cr As on 22 March, 2023 | 06:09
What is the P/E ratio of Torrent Pharmaceuticals ?
The P/E ratio of Torrent Pharmaceuticals is 61.7 As on 22 March, 2023 | 06:09
What is the PB ratio of Torrent Pharmaceuticals ?
The PB ratio of Torrent Pharmaceuticals is 8.6 As on 22 March, 2023 | 06:09
What were the company's most recent reported sales and net income?
Torrent Pharmaceuticals Ltd recorded a net sales of INR 8508 crores in the year ending March 2022.
What is the future of the company's shares?
Torrent Pharmaceuticals Ltd stock is a good option for long-term investment since the stock prices indicate a strong buying trend.
How to buy shares of Torrent Pharmaceuticals Ltd.?
The company's shares can be bought online or offline by opening a Demat account with 5Paisa and verifying the KYC documents.